Study details
Enrolling now
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Albert Einstein Healthcare Network
NCT IDNCT06225830ClinicalTrials.gov data as of Apr 2026
Target enrollment
24
Study length
about 2.1 years
Ages
18+
Locations
1 site in PA
About this study
Researchers are testing if using a robotic device called the Eksobionic Exoskeleton (Esko) can help people with Parkinson's disease improve their walking, balance, and overall quality of life. The trial will involve an eight-week training program with the Esko device, followed by ongoing monitoring to assess its long-term effects.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Eksobionics Eksoskeleton NR
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Gait endurance- 6MWT, Quality of Life- WHOQOL-BREF
Body systems
Neurology